Jaguar Health, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · San Francisco, CA
JAGX chart
What traders are saying about $JAGX
Latest postsJaguar Health, Inc. news
- Weekly Recap: NDA for crofelemer in MVID and $75M shelf S-3
TradingView ·
- Jaguar Health, Inc. Estimates – NASDAQ:JAGX
TradingView ·
- Form S-3 Jaguar Health Inc For: 22 October By Investing.com
Investing.com Nigeria ·
- Jaguar Health - Registers $75 Million Of Securities Under Form S-3 - SEC Filing
TradingView ·
- Jaguar Health Submits $75M S-3 Shelf Registration Statement to SEC
Kalkine Media ·
- Jaguar Health's Affiliate Advances Crofelemer Use for Infant Int
GuruFocus ·
- Jaguar Health unit treats infant with rare intestinal disorder
Investing.com ·
- Jaguar Health's Crofelemer Shows Benefit for Intestinal Failure (IF) in Third Rare Congenital Enteropathy Disorder
Yahoo Finance ·
- Jaguar Health Provides Update Regarding Special Stock Dividend
Yahoo Finance ·
- Positive Preliminary Results Presented at Annual American College of Gastroenterology Meeting for Open-Label Study in Adult Short Bowel Syndrome Patients with Intestinal Failure (SBS-IF) with Jaguar Health's Crofelemer
Yahoo Finance ·
- Reminder: Today, October 13, 2026, is the Record Date for Jaguar Health's Special Stock Dividend
Yahoo Finance ·
- Jaguar Health Targets Mid-2027 MVID NDA Filing as Crofelemer Intestinal Failure Program Advances
investorshub.advfn.com ·
Jaguar Health, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $11.5M | $11.7M | $9.8M | $12.0M |
| Net income | -$54,000 | -$39,250 | -$41,900 | -$48,400 |
| Diluted EPS | $-22.97 | $-130.69 | $-2678.17 | $-36.18 |
| Total assets (year end) | $38.3M | $53.4M | $50.8M | $47.5M |
| Cash and equivalents (year end) | $968,000 | $8.0M | $6.5M | $5.5M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Jaguar Health, Inc.
- Ticker
- JAGX (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- San Francisco, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1585608
- Former names
- Jaguar Animal Health, Inc.
Frequently asked questions
What exchange is Jaguar Health, Inc. listed on?
Jaguar Health, Inc. trades on the Nasdaq under the ticker symbol JAGX.
What industry is Jaguar Health, Inc. in?
Jaguar Health, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Jaguar Health, Inc. headquartered?
Jaguar Health, Inc.'s business address on file with the SEC is in San Francisco, CA.
When does Jaguar Health, Inc.'s fiscal year end?
Jaguar Health, Inc.'s fiscal year ends on December 31.
How much revenue did Jaguar Health, Inc. report?
Jaguar Health, Inc. reported $11.5M in revenue for calendar year 2025, according to its SEC filings.